G57321FI

Summary
GlyTouCan ID
G57321FI
IUPAC Condensed
GalNAc(a1-
Motifs
Tn antigen
GlyConnect structure
GlyGen
ChEBI
PubChem Compound
PubChem Substance
The Human Metabolome Database
3D Structures
GlycoNAVI
G57321FI
GlycoShape
G57321FI
GLYCAM
DGalpNAca1-OH
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying all 4 entries
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
B3GNT6 UDP-GlcNAc
G57321FI
[alpha]-pNP
G00035MO
[alpha]-pNP
Displaying entries 1 - 5 of 9 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
C1GALT1 (not applicable)
G57321FI
Ser/Thr
G00031MO
Ser/Thr
ST6GALNAC1 CMP-Neu5Ac
G57321FI
[Ala-Thr(*)-Ala]2-7
G36123IU
[Ala-Thr(*)-Ala]2-7
ST6GALNAC1 CMP-Neu5Ac
G57321FI
O-glycan Synthesis
G36123IU
O-glycan Synthesis
ST6GALNAC1 CMP-Neu5Ac
G57321FI
Ser/Thr
G36123IU
Ser/Thr
ST6GALNAC4 CMP-Neu5Ac
G57321FI
benzyl
G36123IU
benzyl
Displaying entries 1 - 5 of 35 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
ST8SIA6 CMP-Neu5Ac
G57321FI
ST6GALNAC2 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GAL2 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GAL1 CMP-Neu5Ac
G57321FI
para-nitrophenol
ST6GALNAC3 CMP-Neu5Ac
G57321FI
Ser/Thr
GlycoEpitope
Epitope ID
EP0021
Epitope Name
Tn Antigen
Pathway
Displaying entries 1 - 10 of 57 in total
Pathway Name Organism
E.coli O101 Escherichia coli
E.coli O103 Escherichia coli
E.coli O107 Escherichia coli
E.coli O112ab Escherichia coli
E.coli O112ac Escherichia coli
E.coli O116 Escherichia coli
E.coli O117 Escherichia coli
E.coli O125ab Escherichia coli
E.coli O127 Escherichia coli
E.coli O128ab-H27 Escherichia coli
Sequence Descriptors
GlycoCT
RES
1b:a-dgal-HEX-1:5
2s:n-acetyl
LIN
1:1d(2+1)2n
WURCS
WURCS=2.0/1,1,0/[a2112h-1a_1-5_2*NCC/3=O]/1/
Literature
Displaying entries 1 - 10 of 2052 in total
PubMed ID Title First Author Publication Date Source
38839445 Personalized dosage of Givosiran in acute intermittent porphyria Garrido Montes M 2024 Sep 13
  • PubChem
39232672 Role of the GalNAc-galectin pathway in the healing of premature rupture of membranes Chen JL 2024 Sep 04
  • PubChem
39222205 RNAi targeting LMAN1-MCFD2 complex promotes anticoagulation in mice Ma S 2024 Sep 02
  • PubChem
39477529 Development of bioconjugate-based delivery systems for nucleic acids Wahane A 2024 Oct 30
  • PubChem
39168524 Nonclinical Pharmacokinetics Study of OLX702A-075-16, N-Acetylgalactosamine Conjugated Asymmetric Small Interfering RNA (GalNAc-asiRNA) Ban J 2024 Oct 16
  • PubChem
39379811 The utilization of N-acetylgalactosamine and its effect on the metabolism of amino acids in Erysipelotrichaceae strain Zhou M 2024 Oct 09
  • PubChem
39361617 Aglycone Analysis and Quantitative Tracking of Correlated Terminal Glycan Pair on Spermatozoa Xu L 2024 Oct 03
  • PubChem
39363243 Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study Sardh E 2024 Oct 03
  • PubChem
38992557 Canadian guidance for diagnosis and management of acute hepatic porphyrias Francisco Idiaquez J 2024 Oct
  • PubChem
39528231 Improved In Vivo Metabolic Stability and Silencing Efficacy of siRNAs with Phosphorothioate Linkage-Free, GalNAc-Conjugated Sense Strands Containing Morpholino-LNA Modifications Datta D 2024 Nov 11
  • PubChem
PubAnnotation
Displaying entries 6 - 10 of 10 in total
Title Authors Source Publication Date PubMed ID
Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
  • Lehoux S
  • Mi R
  • Aryal RP
  • Wang Y
  • Schjoldager KT
  • Clausen H
  • van Die I
  • Han Y
  • Chapman AB
  • Cummings RD
  • Ju T
Mol Cell Proteomics 2014 Nov 25071157
Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL).
  • van Vliet SJ
  • Vuist IM
  • Lenos K
  • Tefsen B
  • Kalay H
  • GarcĂ­a-Vallejo JJ
  • van Kooyk Y
J Biol Chem 2013 Sep 20 23918927
Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
  • De Silva RA
  • Wang Q
  • Chidley T
  • Appulage DK
  • Andreana PR
J Am Chem Soc 2009 Jul 22 19552408
Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
  • King MJ
  • Chan A
  • Roe R
  • Warren BF
  • Dell A
  • Morris HR
  • Bartolo DC
  • Durdey P
  • Corfield AP
Glycobiology 1994 Jun 7949653
Carbohydrate receptor-mediated gene transfer to human T leukaemic cells.
  • Thurnher M
  • Wagner E
  • Clausen H
  • Mechtler K
  • Rusconi S
  • Dinter A
  • Birnstiel ML
  • Berger EG
  • Cotten M
Glycobiology 1994 Aug 7827404

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.2.1

Last updated: April 7, 2025